Israel's Cellebrite Q3 revenue beats on strong international demand

By Reuters News


Overview

  • Israel digital intelligence firm's Q3 revenue rose 18% yr/yr, beating analyst expectations

  • Adjusted EBITDA for Q3 beat analyst estimates

  • Q3 net income missed analyst expectations


Outlook

  • Cellebrite sees Q4 revenue of $145 mln to $150 mln

  • Company expects full-year 2026 revenue of $553 mln to $558 mln

  • Cellebrite raises full-year 2026 adjusted EBITDA outlook to $163 mln to $166 mln


Result Drivers

  • INTERNATIONAL AND FEDERAL GROWTH - Co said topline expansion was driven by strong international performance and accelerated growth in U.S. Federal business

  • GENESIS AI SOLUTION - Genesis, the company's new AI-powered solution, gained meaningful traction in its first full quarter

  • PRODUCT INNOVATION - Co cited new and enhanced AI capabilities, expanded access for mobile phones and drones, and the launch of a new mobile forensics field kit as recent product highlights


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Revenue

Beat

$149.02 mln

$145.92 mln (8 Analysts)

Q3 Net Income

Miss

$26.66 mln

$39.73 mln (4 Analysts)

Q3 Adjusted EBITDA

Beat

$53.63 mln

$43.34 mln (7 Analysts)

Q3 Gross Margin

81.20%


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the software peer group is "buy"

  • Wall Street's median 12-month price target for Cellebrite DI Ltd is $15.00, about 18.1% above its November 11 closing price of $12.70

  • The stock recently traded at 20 times the next 12-month earnings vs. a P/E of 24 three months ago


Reuters Recommended Reads

  • Nov 12 - Israel's Allot Q3 revenue rises 16%, beats estimates on cybersecurity demand

  • Nov 9 - Israel's Monday.com Q3 revenue rises 19%

  • Nov 10 - Israeli AI security startup Bay raises $50 million


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.